[{"AccountsPayableCurrent_0_Q1_USD":15114000.0,"AccruedInvestmentIncomeReceivable_0_Q1_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":73000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":40.41,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":4829454.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7343000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-982000.0,"PaymentsToAcquireInvestments_1_Q1_USD":4420000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":150314000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":175000.0,"EarningsPerShareDiluted_1_Q1_USD":-2.84,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":31070000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1014000.0,"OtherCostAndExpenseOperating_1_Q1_USD":31000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-14000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-78263000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":3213000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":27519229.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":31070000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":234940.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":34.92,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3160857.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":28706000.0,"EarningsPerShareBasic_1_Q1_USD":-2.84,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7053000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":408000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":9000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-16744000.0,"RestrictedCash_0_Q1_USD":928000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":34702000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":31200000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-14000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.04,"OperatingLeaseRightOfUseAsset_0_Q1_USD":5510000.0,"OperatingLeasePayments_1_Q1_USD":200000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3719000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1913000.0,"OperatingLeaseLiability_0_Q1_USD":5632000.0,"OperatingLeaseCost_1_Q1_USD":200000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":331000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1589000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1975000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1928000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":471000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":5963000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":523000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":1143000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":56000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1170000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":7931000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":61.14,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":25.21,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":40.41,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":191000.0,"NetIncomeLoss_1_Q1_USD":-78249000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-69347000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":26589000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":26014000.0,"LiabilitiesCurrent_0_Q1_USD":73453000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":179642000.0,"Liabilities_0_Q1_USD":229888000.0,"InventoryNet_0_Q1_USD":1841000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2538000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-13650000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"Depreciation_1_Q1_USD":106000.0,"CommonStockValue_0_Q1_USD":28000.0,"CommonStockSharesOutstanding_0_Q1_shares":27548133.0,"CommonStockSharesIssued_0_Q1_shares":27548133.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":149386000.0,"AssetsCurrent_0_Q1_USD":172629000.0,"Assets_0_Q1_USD":179642000.0,"AssetImpairmentCharges_1_Q1_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5219216.0,"AdditionalPaidInCapital_0_Q1_USD":723232000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":9000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":11354000.0,"ProfitLoss_1_Q1_USD":-78249000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1447000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-773515000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4829454.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":48.24,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":43282.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":368000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":11451000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1841000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":27519229.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1014000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":40133.0,"ShareBasedCompensation_1_Q1_USD":7053000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":41553000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1840000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-74446000.0,"OperatingExpenses_1_Q1_USD":76286000.0,"InterestExpense_1_Q1_USD":4171000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":16656000.0,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":-50246000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]